Physician

Deepthi Kodali, M.D.

According to 2025 Medicare claims, Deepthi Kodali, M.D. (NPI: 1750738860) practices hematology/oncology in the Spokane-Spokane Valley, WA market, with the plurality of this provider's patient population coming from Spokane, WA. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 99216-2759. Kodali is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), PSW ACO (ACO ID: A5323), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Kodali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 258 traditional Medicare patients, billed 55,842 HCPCS/CPT codes, and received $941,497 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 370 prescription claims across 68 beneficiaries totaling $1,054,267 in drug costs, led by Doptelet (Avatrombopag Maleate). Open Payments data shows 89 records totaling $2,387. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,063 to $1,054,267. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$471K$941K2023 Medicare payment: $206,930 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $941,497 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20231026,926$206,930
202425855,842$941,497

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$527K$1.1M2016 Drug cost: $1,063 (USD; Tot_Drug_Cst)2017 Drug cost: $16,468 (USD; Tot_Drug_Cst)2018 Drug cost: $41,531 (USD; Tot_Drug_Cst)2019 Drug cost: $11,064 (USD; Tot_Drug_Cst)2020 Drug cost: $1,306 (USD; Tot_Drug_Cst)2021 Drug cost: $1,206 (USD; Tot_Drug_Cst)2023 Drug cost: $136,187 (USD; Tot_Drug_Cst)2024 Drug cost: $1,054,267 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161240$1,063
201757238$16,468
201870497$41,531
201938192$11,064
20201522$1,306
2021N/R20$1,206
2022N/RN/RN/R
20232253$136,187
202468370$1,054,267

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more92243$98
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more110164$69
80053Blood test, comprehensive group of blood chemicals73108$10
36415Insertion of needle into vein for collection of blood sample113276$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count121367$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
DopteletAvatrombopag Maleate14409$167,546
XtandiEnzalutamide11330$150,974
Abiraterone AcetateAbiraterone Acetate12360$47,318
EliquisApixaban11390$7,668
Ondansetron OdtOndansetron26585$1,442

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.89$2,387Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Deepthi Kodali, M.D.?

Tedicare shows public-source Medicare data for Deepthi Kodali, M.D. (NPI 1750738860), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Deepthi Kodali, M.D. have ACO affiliation data?

Deepthi Kodali, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), PSW ACO (MSSP, ACO ID A5323), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Deepthi Kodali, M.D.?

Deepthi Kodali, M.D. is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Deepthi Kodali, M.D. have Open Payments data?

Deepthi Kodali, M.D. has 89 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.